High resistance of atrioventricular node to cryoablation: a great safety margin targeting perinodal arrhythmic

Nicasio Pérez-Castellano1, Julián Villacastín, Javier Moreno

  • 1Unit of Arrhythmias, Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain. nperez.hcsc@salud.madrid.org

Heart Rhythm
|October 5, 2006
PubMed
Abstract

Insights

Cryoablation of the atrioventricular (AV) node shows a high safety margin, with a low rate of persistent conduction impairment. This suggests cryothermal ablation is a safe option for AV nodal ablation procedures.

Area of Science:

  • Electrophysiology
  • Cardiovascular Medicine
  • Medical Technology

Background:

  • Animal studies and limited patient data suggest cryoenergy is safer than radiofrequency for ablating tissue near the AV node.
  • Defining the safety margin of cryothermal ablation for AV nodal ablation is crucial for clinical practice.

Purpose of the Study:

  • To systematically assess the electrophysiologic effects of cryoenergy on the human AV node.
  • To establish the safety profile of cryothermal ablation in the AV nodal region.

Main Methods:

  • 15 patients undergoing AV nodal ablation received 94 cryomapping and 105 cryoablation applications.
  • A 6-mm-tip cryothermal ablation catheter was used at specific sites within the triangle of Koch.

Main Results:

  • Temporary AV conduction effects occurred in 19% of cryomapping and 36% of cryoablation applications.
  • Persistent effects were noted in 9% of cryoablation applications, associated with specific locations and temperatures (< -79°C) and onset times (< 15s).
  • Complete AV block was achieved with cryoenergy in only one patient; radiofrequency was used for definitive block in others.

Conclusions:

  • Cryoablation of the AV node demonstrates a favorable safety margin due to a low incidence of persistent conduction abnormalities.
  • Perinodal cryothermal ablation appears to be a safe therapeutic option for AV nodal ablation.

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...